Yi Larson
Director/Board Member bei OLEMA PHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Profil
Frau Yi Larson ist ein unabhängiges Vorstandsmitglied bei Olema Pharmaceuticals, Inc. Sie ist Mitglied des Board of Directors bei Olema Pharmaceuticals, Inc. und Rayzebio, Inc. Frau Larson war zuvor als Chief Financial Officer & Executive Vice President bei Turning Point Therapeutics, Inc. beschäftigt. Sie erhielt ihren Bachelor-Abschluss von der Wharton School der University of Pennsylvania, einen Graduierten-Abschluss vom Massachusetts Institute of Technology und einen MBA von der Wharton School der University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LIANBIO
-.--% | 10.04.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
16.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Yi Larson
Unternehmen | Position | Beginn |
---|---|---|
OLEMA PHARMACEUTICALS, INC. | Director/Board Member | 06.04.2021 |
Ehemalige bekannte Positionen von Yi Larson
Unternehmen | Position | Ende |
---|---|---|
RAYZEBIO, INC. | Director/Board Member | 26.02.2024 |
LIANBIO | Director of Finance/CFO | 19.12.2023 |
TURG POIN | Director of Finance/CFO | 31.03.2021 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Ausbildung von Yi Larson
Massachusetts Institute of Technology | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OLEMA PHARMACEUTICALS, INC. | Health Technology |
RAYZEBIO, INC. | Health Technology |
LIANBIO | Health Technology |
Private Unternehmen | 2 |
---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |